Bogart Wealth’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.62K Hold
18
– – ﹤0.01% 1198
2026
Q2
$5.69K Hold
18
– – ﹤0.01% 1165
2026
Q1
$3.59K Hold
18
– – ﹤0.01% 1147
2025
Q4
$3.4K Hold
18
– – ﹤0.01% 1078
2025
Q3
$3.19K Hold
18
– – ﹤0.01% 1055
2025
Q2
$2.05K Hold
18
– – ﹤0.01% 1102
2025
Q1
$1.89K Sell
18
-19
-51% -$2.15K ﹤0.01% 1081
2024
Q4
$3.96K Buy
+37
New +$4.18K ﹤0.01% 943
2022
Q4
– Sell
-16
Closed -$1K – 1133
2022
Q3
$1K Buy
+16
New +$941 ﹤0.01% 913

Other funds holding LGND

Bogart Wealth's LGND Position: Q3 2026 in Review

Bogart Wealth held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 18 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Bogart Wealth first reported a position in LGND in Q3 2022 and has held it in 9 quarters since. The position peaked at $5.69K in Q2 2026. 434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Bogart Wealth held 18 shares of Ligand Pharmaceuticals worth $5.62K as of Q3 2026.
  • Bogart Wealth left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1198 holding.
  • Bogart Wealth first reported a position in Ligand Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
  • Bogart Wealth's Ligand Pharmaceuticals position peaked at $5.69K in Q2 2026.
  • 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.